Med-x

NOV 5, 2026 · JOURNAL ARTICLE

Bioengineering strategies for off-the-shelf, cell-based cancer immunotherapy

Med-x

Cancer immunotherapy has reshaped modern oncology by leveraging immune effector cells to recognize and eliminate malignant tissues. Among cell-based approaches, adoptive cell thera

OCT 9, 2026 · JOURNAL ARTICLE

Identifying brain-computer interface translational priorities with an outlook on the field in 2035

Med-x

Brain–computer interfaces (BCIs) have advanced rapidly, particularly over the past few decades, evolving from experimental demonstrations to powerful research tools and early-stage